Caricamento...
(177)Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
The use of an albumin binder has been shown to improve tumor uptake of prostate-specific membrane antigen (PSMA)–targeting radiotherapeutic agents. The aim of this study was to develop improved radiotherapeutic agents that combine an optimized affinity-modifying group and optimized albumin binders t...
Salvato in:
| Pubblicato in: | J Nucl Med |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Society of Nuclear Medicine
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049373/ https://ncbi.nlm.nih.gov/pubmed/32859704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.120.250738 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|